1Ng CS,Wan S,Yim AP,et al.Pulmonarydysfunction after cardiac surgery[J].Chest,2002,121:1269-1277.
2Milot J,Perron J,Lacasse Y,et al.Incidence and predictors of ARDS after cardiacsurgery[J].Chest,2001,119(3):884-885.
3Massoudy P,Zahler S,Becker BF,et al.Evidence for inflammatory responses of the lungsduring coronary artery bypass grafting with cardiopulmonarybypass[J].Chest,2001,119(1):31-36.
4Chaney MA,Durazo-Arvizu RA,Nikolov MP,et al.Methylprednisolone does not benefitpatients undergoing coronary artery bypass grafting and early tracheal extubation[J].JThorac Cardiovasc Surg,2001,121(3):561-569.
5Lamarche Y,Malo O,Thorin E,et al.Inhaled but not intravenous milrinone preventspulmonary endothelial dysfunction after cardiopulmonary bypass[J].J Thorac CardiovascSurg,2005,130(1):83-92.
6Khazin V,Kaufman Y,Zabeeda D,et al.Milrinone and nitric oxide:combined effect onpulmonary artery pressures after cardiopulmonary bypass in children[J].J Cardiothorac VascAnesth,2004,18(2):156-159.
8Chen YF,Tsai WC,Lin CC,et al.Effect of leukocyte depletion on endothelial cellactivation and transendothelial migration of leukocytes during cardiopulmonarybypass[J].Ann Thorac Surg,2004,78:634-642.
9Efstathiou A,Vlachveis M,Tsonis G,et al.Does leukodepletion during elective cardiacsurgery really influence the overall clinical outcome[J]? J CardiovascSurg,2003,44(2):197-204.
10Ilmakunnas M,Pesonen EJ,Ahonen J,et al.Activation of neutrophils and monocytes by aleukocyto depleting filter used throughout cardiopulmonary bypass[J].J Thorac CardiovascSurg,2005,129(4):851-859.
